Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HIMS Hims & Hers Health Inc.

Post-Market Trading 03-31 18:53:49 EDT

29.55

+0.41

+1.41%

盘后29.42

-0.13-0.44%

18:53 EDT

High30.17	Low27.22	Vol19.84M
Open27.77	D1 Closing29.14	Amplitude10.12%
Mkt Cap6.56B	Tradable Cap5.69B	Total Shares222.17M
T/O574.59M	T/O Rate10.30%	Tradable Shares192.64M
P/B13.77	ROE30.71%	EPS0.53
52wk High72.98	52wk Low11.20	P/E55.52
Dividend0.00	Div.Yield0.00	ROA7.18%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":29.55,"timestamp":1743451200000,"preClose":29.14,"halted":0,"volume":19837122,"hourTrading":{"tag":"盘后","latestPrice":29.42,"preClose":29.55,"latestTime":"18:53 EDT","volume":335478,"amount":9904094.572086,"timestamp":1743461623019},"delay":0,"floatShares":192643366,"shares":222165572,"eps":0.532235,"marketStatus":"Post-Market Trading","change":0.41,"latestTime":"03-31 18:53:47 EDT","open":27.77,"high":30.17,"low":27.22,"amount":574591621.688706,"amplitude":0.101235,"askPrice":29.6,"askSize":2,"bidPrice":29.25,"bidSize":50,"shortable":3,"etf":0,"ttmEps":0.532235,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743465600000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":29.14,"preHourTrading":{"tag":"盘前","latestPrice":27.6,"preClose":29.14,"latestTime":"09:29 EDT","volume":323643,"amount":8917802.595849,"timestamp":1743427799999},"postHourTrading":{"tag":"盘后","latestPrice":29.42,"preClose":29.55,"latestTime":"18:53 EDT","volume":335478,"amount":9904094.572086,"timestamp":1743461623019},"volumeRatio":1.016668,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1743739200000,"strike":"37.5","timestamp":1743436078278,"price":0.07,"volume":2000,"amount":14000,"type":"+"},{"symbol":"HIMS","call":true,"expireDate":1743739200000,"strike":"32.0","timestamp":1743436078278,"price":0.46,"volume":2000,"amount":92000,"type":"+"}]},"impliedVol":1.4036,"impliedVolPercentile":0.9602},"requestUrl":"/m/hq/s/HIMS/wiki","defaultTab":"wiki","newsList":[{"id":"2523478419","title":"1 Stock Under $50 on Our Watchlist and 2 to Turn Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2523478419","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523478419?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 21:02","pubTimestamp":1743426121,"startTime":"0","endTime":"0","summary":"The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here is one stock under $50 with huge potential and two best left ignored.Operating as a critical behind-the-scenes partner for complex technology products since 1979, Benchmark Electronics  provides advanced manufacturing, engineering, and technology solutions for original equipment manufacturers across aerospace, medical, industrial, and technology sectors.Customers postponed purchases of its products and services this cycle as its revenue declined by 4.1% annually over the last two years. Low free cash flow margin of 0.6% for the last five years gives it little breathing room, constra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/1-stock-under-50-watchlist-130201498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BHE","BK4196","HIMS","BK4145","PINC"],"gpt_icon":1},{"id":"2523636686","title":"3 Growth Companies With Insider Ownership Up To 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523636686","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523636686?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 01:05","pubTimestamp":1743181529,"startTime":"0","endTime":"0","summary":"As the U.S. market grapples with heightened inflation concerns and wavering consumer sentiment, major indices like the Dow Jones, S&P 500, and Nasdaq have experienced notable declines. Amid these turbulent times, investors often seek solace in growth companies where insider ownership is high, as this can signal confidence from those closest to the business.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.Overview: A2Z Cust2Mate Solutions Corp. is a technology company that develops and commercializes retail smart cart solutions for grocery stores and supermarkets in Israel and internationally, with a market cap of $257.77 million.Overview: Dingdong  Limited is an e-commerce company operating in China with a market cap of approximately $617.19 million.Operations: The company's revenue is primarily derived from its online retail segment, which amou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-growth-companies-insider-ownership-170529448.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861217088.USD","BK4196","BK4551","DDL","HIMS","LU1861220207.SGD","BK4211","LOB","TBBB","BK4539","BK4113","AZ"],"gpt_icon":1},{"id":"2522058245","title":"March 2025's Top Growth Stocks With High Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2522058245","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522058245?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 01:05","pubTimestamp":1743095136,"startTime":"0","endTime":"0","summary":"As the U.S. market grapples with recent tariff announcements and economic uncertainties, major indices like the Dow Jones, S&P 500, and Nasdaq Composite have seen fluctuations that reflect investor caution. In such a climate, growth companies with high insider ownership can be particularly appealing to investors seeking confidence in management's commitment to long-term success.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.Operations: The company's revenue is primarily derived from its banking segment, totaling $91.11 million.Overview: Mama's Creations, Inc. manufactures and markets fresh deli-prepared foods primarily in the United States, with a market cap of $250.70 million.Operations: The company generates revenue through its food processing segment, which amounted to $116.47 million.Mama's Creations is poised for substantial growth, with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/march-2025s-top-growth-stocks-170536225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4116","COFS","BK4196","HIMS","BK4113","TBBB","BIGC","MAMA"],"gpt_icon":1},{"id":"2521727948","title":"Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521727948","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521727948?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 20:01","pubTimestamp":1742817660,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc.  shares rallied 5.7% in the last trading session to close at $34.75. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 50.5% loss over the past four weeks.The recent surge in Hims & Hers Health Inc.'s shares can be attributed to the strong fourth-quarter and full-year 2024 results, highlighted by a 95% YoY increase in quarterly revenue to $246.6 million and 65% full-year revenue growth to $872 million, alongside positive adjusted EBITDA margins. Investor confidence is further boosted by the company’s 2025 outlook, projecting revenue between $1.17 billion and $1.20 billion, and continued profitability. Despite regulatory challenges around compounded weight-loss medications, Hims & Hers’ strategic diversification and 48% YoY subscriber growth to 1.5 million underpin optimism for sustained growth.Hims & Hers Health belongs to the Zacks Medical Info Systems industry. A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hims-hers-health-hims-moves-120100431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HIMS","FLGT","BK4196"],"gpt_icon":1},{"id":"2521721051","title":"With A 29% Price Drop For Hims & Hers Health, Inc. (NYSE:HIMS) You'll Still Get What You Pay For","url":"https://stock-news.laohu8.com/highlight/detail?id=2521721051","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521721051?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 18:22","pubTimestamp":1742811743,"startTime":"0","endTime":"0","summary":"The Hims & Hers Health, Inc. ( NYSE:HIMS ) share price has softened a substantial 29% over the previous 30 days...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/with-a-29-price-drop-for-hims-hers-health-inc-nysehims-youll","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","HIMS","NYSE"],"gpt_icon":1},{"id":"2520151806","title":"Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2520151806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520151806?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 23:54","pubTimestamp":1742399640,"startTime":"0","endTime":"0","summary":"Today was supposed to mark the beginning of the end for cheaper, knockoff versions of hot weight-loss drugs. The Food and Drug Administration wants bulk production of the copycats to stop -- starting Wednesday for pharmacy-prepared versions of Zepbound and later in the spring for knockoffs of Ozempic and Wegovy.But telehealth companies and pharmacies that have fueled wide use of copycats have other plans.Telehealth platform Hims & Hers Health says it will keep offering pharmacy-made, or compounded, versions of Ozempic and Wegovy tweaked to individual prescriptions. And some of the pharmacies making the GLP-1 drug copycats will continue, according to people familiar with the industry.Demand for the weight-loss drugs increased so much, so quickly that Eli Lilly and Novo Nordisk couldn't keep up. Due to the shortages, pharmacies that make custom-made, or compounded, versions were allowed to help fill the gap.Since ramping up production, Eli Lilly, which makes Mounjaro and Zepbound, and No","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018865.SGD","LU2237443622.USD","SG9999001176.USD","BK4599","LU1917777945.USD","HIMS","LLY","LU0203202063.USD","LU0097036916.USD","LU0320765059.SGD","LU0289739699.SGD","LU1868837136.USD","LU1064131342.USD","NVO","BK4581","LU0198837287.USD","LU2468319806.SGD","LU2089984988.USD","BK4585","IE00B4R5TH58.HKD","LU1267930730.SGD","LU1061106388.HKD","LU1814569148.SGD","LU1868836757.USD","IE00BKVL7J92.USD","LU1983299246.USD","LU0820561818.USD","LU0256863902.USD","LU1035775433.USD","LU2361044865.SGD","SG9999018857.SGD","LU2237443895.HKD","LU1548497426.USD","LU1551013342.USD","LU0096364046.USD","SG9999013999.USD","LU1366192091.USD","LU2237438978.USD","LU2237443549.SGD","LU0456855351.SGD","LU2063271972.USD","LU1988902786.USD","LU0820561909.HKD","IE0002141913.USD","SG9999017495.SGD","LU0640476718.USD","LU1720051108.HKD","SGXZ57979304.SGD","LU0672654240.SGD","LU1023059063.AUD"],"gpt_icon":1},{"id":"2520672278","title":"2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2520672278","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520672278?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 21:01","pubTimestamp":1742302875,"startTime":"0","endTime":"0","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.4%. This performance was disappointing since the S&P 500 held its ground.Despite the lackluster result, a few diamonds in the rough can produce earnings growth no matter what, and we started StockStory to help you find them. Keeping that in mind, here are two healthcare stocks we think can generate sustainable market-beating returns and one that may face trouble.With a unique business model combining end-of-life care and household services, Chemed  operates two distinct businesses: VITAS, which provides hospice care for terminally ill patients, and Roto-Rooter, which offers plumbing and water restoration services.Muted 4.6% annual revenue growth over the last five years shows it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/2-healthcare-stocks-solid-fundamentals-130115144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HIMS","IE00B64QTZ34.USD","CHE","BK4532","LU1571399168.USD","HCSG","IE00BLDYK493.USD","BK4139","LU1699723380.USD","BK4137","BK4196","UTHR"],"gpt_icon":1},{"id":"2520649326","title":"Hims & Hers Health Inc : Bofa Global Research Raises Price Objective to $22 From $21","url":"https://stock-news.laohu8.com/highlight/detail?id=2520649326","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520649326?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 18:01","pubTimestamp":1742292090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q10KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"2519285764","title":"Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2519285764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519285764?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 01:17","pubTimestamp":1741886274,"startTime":"0","endTime":"0","summary":"Shares in telehealth business Hims & Hers Health ($HIMS) dropped over 6% today after reports that it and peers are marketing hair-loss treatments t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-hers-hims-investors-pulling-their-hair-out-over-pills-side-effects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-hers-hims-investors-pulling-their-hair-out-over-pills-side-effects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMS","BK4211","BK4196","ISBC"],"gpt_icon":0},{"id":"2519304828","title":"2 High-Flying Stocks with Exciting Potential and 1 to Turn Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2519304828","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519304828?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 21:01","pubTimestamp":1741870897,"startTime":"0","endTime":"0","summary":"\"You get what you pay for\" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.Finding the right balance between price and quality can challenge even the most skilled investors. Luckily for you, we started StockStory to help you identify the real opportunities. Keeping that in mind, here are two high-flying stocks expanding their competitive advantages and one climbing an uphill battle.Called upon when disasters strike and complex technical questions need answers, Exponent  is a scientific and engineering consulting firm that investigates complex problems and provides solutions across various industries.Subscale operations are evident in its revenue base of $518.5 million, meaning it has fewer distribution channels than its larger rivals. Earnings per share lagged its peers over the last two years as they o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/2-high-flying-stocks-exciting-130137347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1854104046.USD","LU2089279066.USD","LU2298321311.HKD","BK4120","LU2092937221.SGD","LU2413666426.HKD","LU0347712357.USD","LU0154245756.USD","LU2041044095.USD","LU0154245673.USD","LU0385154629.USD","LU0471298694.HKD","BK4585","BK4123","BK4588","LU2240825500.USD","LU0471298777.SGD","LU1854103824.USD","BK4196","LU2229751404.USD","LU2355687059.USD","LU2360106947.USD","BK4533","HIMS","LU1585245621.USD","LU1721428933.USD","LU1430594728.SGD","RSG","EXPO","LU2413666699.HKD","IE00B64QTZ34.USD","LU2360108059.USD"],"gpt_icon":1},{"id":"2519833811","title":"These 20 stocks are likely to be losers no matter what the market does","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833811?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:45","pubTimestamp":1741866300,"startTime":"0","endTime":"0","summary":"Certain stocks are likely to lose money, even if the U.S. stock market stops declining and starts rising again.No one knows if the stock market decline that began on Feb. 19 will be the beginning of a major bear market, of course. But a recent study found that certain stocks are good bets to lose money, regardless of how the overall stock market performs. The study, entitled \"The Dynamics of Disagreement,\" was conducted by Kent Daniel of Columbia Business School, Alexander Klos of Germany's Kiel University and Simon Rottke of the University of Amsterdam. . On several occasions in recent years I've applied the study's methodology to stocks within the S&P 1500, constructing updated lists of Constrained Winners and Constrained Losers. The most recent list was published in early April 2024, and the stocks mentioned have performed as expected. The Constrained Winners list produced an average loss of 8.4% , while the Constrained Losers produced an average loss of 9.3%. Over the same period, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GME","BK4588","LU0149725797.USD","BK4170","LU2065731478.USD","CLF","MRNA","BK4213","BK4089","BK4547","BK4568","BK4585","BK4196","CELH","BK4532","BK4548","HIMS","LU2211815571.USD","BK4551","LUMN","BK4577","LU0053671581.USD","BK4177","BK4543","LU1861220033.SGD","BK4139","BK4501","BK4076","BK4535","LU1861215975.USD","BK4533","BK4006","TPL","BK4554","SMCI","BK4534"],"gpt_icon":1},{"id":"2519838796","title":"Insider-Favored Growth Stocks To Watch Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838796","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838796?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:05","pubTimestamp":1741863935,"startTime":"0","endTime":"0","summary":"As the U.S. markets show signs of recovery with the S&P 500 and Nasdaq rising after an encouraging CPI inflation report, investors are keenly watching for growth opportunities amidst ongoing economic uncertainties. In this context, companies with high insider ownership often attract attention as they can signal confidence in future performance, making them intriguing options for those looking to navigate the current market landscape.Top 10 Growth Companies With High Insider Ownership In The United States. AerSale Corporation, with significant insider ownership, recently reported a return to profitability, achieving a net income of US$5.85 million for 2024 compared to a loss the previous year. Revenue grew modestly to US$345.07 million. Despite low forecasted Return on Equity at 2.8%, AerSale's earnings are expected to grow significantly at 57.58% annually over the next three years, outpacing both its revenue growth and the broader US market growth rates.Overview: Credo Technology Group","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-favored-growth-stocks-watch-110535883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","VTS","BK4187","TBBB","BK4196","BK4113","CRDO","ASLE","HIMS"],"gpt_icon":1},{"id":"2519837858","title":"They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick. -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2519837858","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519837858?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 17:30","pubTimestamp":1741858200,"startTime":"0","endTime":"0","summary":"Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a bottle of finasteride pills days later. He never spoke to a doctor.Soon after taking the medicine, Millich said he felt strange symptoms. He woke up one day anxious, dizzy and slurring his words. Later his libido plunged, and his genitals shrank and changed shape. His doctor said the symptoms were caused by the drug. His wife, Marie Linne von Berg, said the symptoms upended their lives.The side effects are \"very very common\" these days because the medicine is easier to get from telehealth companies, Houman said. He said the cosmetic benefits of finasteride are almost never worth the risks. \"This is not something young men should take,\" he said.Hims customers \"go through a comprehensive intake that is reviewed by a licensed provider who makes a clinical determination about the patient's eligibil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196"],"gpt_icon":1},{"id":"2519084071","title":"Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2519084071","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519084071?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 13:00","pubTimestamp":1741842000,"startTime":"0","endTime":"0","summary":"MIAMI, March 13, 2025  -- Defiance ETFs introduces RKLX and HIMZ, two 2X leveraged single-stock ETFs designed to provide amplified exposure to Rocket Lab USA, Inc.  and Hims & Hers Health Inc. . These ETFs offer traders a way to seek enhanced returns on Rocket Lab and Hims & Hers without requiring a margin account.“RKLX and HIMZ offer compelling opportunities for investors seeking amplified exposure to Rocket Lab and Hims & Hers, two companies driving innovation in their respective industries,” said Sylvia Jablonski, CEO of Defiance ETFs. “With increasing demand for satellite technology and digital healthcare solutions, Rocket Lab and Hims & Hers continue to play key roles in shaping the future of space exploration and telehealth.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/defiance-launches-rklx-himz-2x-050000075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FDN","BK4550","RKLB","BK4585","BK4588","BK4196","BK4187","HIMS","BK4564"],"gpt_icon":1},{"id":"2518672209","title":"Insiders Favor These 3 High Growth Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518672209","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518672209?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 01:05","pubTimestamp":1741712736,"startTime":"0","endTime":"0","summary":"As the U.S. market grapples with volatility amid tariff announcements and economic uncertainty, investors are keenly observing how these factors impact growth stocks. In such an environment, companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business in its long-term potential.Top 10 Growth Companies With High Insider Ownership In The United States. Overview: Bank of Marin Bancorp, with a market cap of $372.22 million, operates as the holding company for Bank of Marin, offering financial services to small to medium-sized businesses, not-for-profit organizations, and commercial real estate investors in the United States.Click here and access our complete growth analysis report to understand the dynamics of Bank of Marin Bancorp.Our valuation report unveils the possibility Bank of Marin Bancorp's shares may be trading at a discount.Community West Bancshares, with high insider ownership, is positioned for g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insiders-favor-3-high-growth-170536623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BMRC","CWBC","BK4211","BK4023","HIMS","ENFN","BK4113","TBBB"],"gpt_icon":1},{"id":"2518184897","title":"Press Release: Define Ventures Appoints Carolyn Magill as Venture Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2518184897","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518184897?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 17:30","pubTimestamp":1741685400,"startTime":"0","endTime":"0","summary":"The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors. SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.\"Define represents the best of venture -- an incredible founder community and a team of experienced operators who truly understand what it takes to build in healthcare,\" said Magill. \"Throughout my career, I've worked across many corners of healthcare, and joining Define allows me to bring that experience to the earliest stages of innovation, helping founder","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","EVH","BK4196","HIMS","LU0053671581.USD"],"gpt_icon":1},{"id":"2518724203","title":"Hims & Hers Health Discontinues Dermatology Business Apostrophe","url":"https://stock-news.laohu8.com/highlight/detail?id=2518724203","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518724203?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 19:25","pubTimestamp":1741605902,"startTime":"0","endTime":"0","summary":"Hims & Hers Health's  Apostrophe business said it's being discontinued, with all existing subscriptions to be canceled as of March 7.Apostrophe said customers will be able to access provider team and receive support through their patient accounts for the next 30 days, according to a message posted on its website.Hims & Hers shares were down 2.1% in recent premarket activity Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"2518250221","title":"Bet on DuPont Analysis & Pick 5 Quality Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2518250221","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518250221?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 18:32","pubTimestamp":1741602720,"startTime":"0","endTime":"0","summary":"The S&P 500 has just seen its worst week since September due to “tariff fatigue” and fears of severe economic slowdown. Concerns of a future rally remain in place. Investors seek clear signals on trade policies. Analysts suggest that the Federal Reserve is unlikely to rush into cutting interest rates as the central bank will look for more cues regarding the stabilization in the inflation scenario amid trade tensions.As a result, it is intriguing to pick quality stocks at the current stressed investing backdrop. Upbeat return on equity  can serve as one such quality measure. Let’s delve a little deeper.Return on equity is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend in companies and compare this to historical or industry benchmarks to pick a winning stock.So, an investor confined solely to an ROE perspective may be confused if he or she has to judge between two ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bet-dupont-analysis-pick-5-103200853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","BK4113","BK4588","LU2236285917.USD","LU0310799852.SGD","BK4504","IE0031619046.USD","SFM","DD","BLBD","BK4077","LU0052756011.USD","EME","LU0211327993.USD","HIMS","BK4585","LU0053671581.USD","LU0211328371.USD","BK4129","LU1267930227.SGD","LU0310800965.SGD","LU2355687059.USD","BK4196","EVER","IE00B19Z4B17.USD","ROE","LU0128525689.USD","BK4149","BK4532","IE00B7SZL793.SGD","LU0274383776.USD","IE00B66KJ199.SGD","LU1267930490.SGD"],"gpt_icon":1},{"id":"2518260180","title":"Hims & Hers Stock (HIMS) Soars on Plans to Shutter Acne Treatment Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2518260180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518260180?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 14:20","pubTimestamp":1741587610,"startTime":"0","endTime":"0","summary":"Hims & Hers Health ($HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of Hims & Hers’ plan to co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-hers-stock-hims-soars-on-plans-to-shutter-acne-treatment-unit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-hers-stock-hims-soars-on-plans-to-shutter-acne-treatment-unit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMS","BK4196"],"gpt_icon":0},{"id":"2517468431","title":"Hims & Hers Health Shares Pare Gains Slightly With Volume Pickup, Business Insider Reports Shuttering Dermatology Business, Shares Last up 3.5% $35.60 VS Session High of $36.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2517468431","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517468431?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 04:37","pubTimestamp":1741379821,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL2N3PQ16V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMS"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1614},{"period":"1month","weight":-0.3044},{"period":"3month","weight":0.0971},{"period":"6month","weight":0.6398},{"period":"1year","weight":0.8836},{"period":"ytd","weight":0.2051}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oaktree Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the industrial and consumer sectors. The company was founded in 2019 and is based in Los Angeles, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.14307},{"month":2,"riseRate":0.666667,"avgChangeRate":0.154354},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.060306},{"month":4,"riseRate":0.2,"avgChangeRate":-0.059815},{"month":5,"riseRate":0.4,"avgChangeRate":0.08823},{"month":6,"riseRate":0.8,"avgChangeRate":-0.001611},{"month":7,"riseRate":0.6,"avgChangeRate":0.022369},{"month":8,"riseRate":0.4,"avgChangeRate":-0.10346},{"month":9,"riseRate":0.4,"avgChangeRate":0.028662},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.052391},{"month":11,"riseRate":0.833333,"avgChangeRate":0.240153},{"month":12,"riseRate":0.5,"avgChangeRate":0.028825}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}